Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Carr

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Ebiomedicine|December 5, 2021
Genome-Wide association between EYA1 and Aspirin-induced peptic ulcerationStephane Bourgeois, Daniel F Carr, Crispin O Musumba, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Software for Dosage Individualization of Voriconazole: a Prospective Clinical StudyWilliam Hope, Gary Johnstone, Silvia Cicconi, et al.
The Journal of Investigative Dermatology|July 22, 2018
A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for PsoriasisAmy C Foulkes, David S Watson, Daniel F Carr, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2016
Efavirenz and Metabolites in Cerebrospinal Fluid: Relationship with CYP2B6 c.516G→T Genotype and Perturbed Blood-Brain Barrier Due to Tuberculous MeningitisSam Nightingale, Tran Thi Hong Chau, Martin Fisher, et al.
The Journal of Antimicrobial Chemotherapy|August 23, 2014
CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populationsDaniel F Carr, Mas Chaponda, Elena M Cornejo Castro, et al.
The Journal of Investigative Dermatology|December 29, 2022
TNF-α‒Mediated Keratinocyte Expression and Release of Matrix Metalloproteinase 9: Putative Mechanism of Pathogenesis in Stevens‒Johnson Syndrome/Toxic Epidermal NecrolysisAnna Olsson-Brown, Vincent Yip, Emeka D Ogiji, et al.
Diabetologia|January 15, 2026
Identification of a genetic risk factor for metformin-induced vitamin B<sub>12</sub> deficiencyFaye D Baldwin, Khaled F Bedair, Andrea L Jorgensen, et al.
Clinical Pharmacology and Therapeutics|June 21, 2019
Genomewide Association Study of Statin-Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research DatalinkDaniel F Carr, Ben Francis, Andrea L Jorgensen, et al.
Blood|October 17, 2013
CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemiaGillian G Johnson, Ke Lin, Trevor F Cox, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2011
The IL1RN promoter rs4251961 correlates with IL-1 receptor antagonist concentrations in human infection and is differentially regulated by GATA-1Enitan D Carrol, Antony Payton, Deborah Payne, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Ebiomedicine|December 5, 2021
Genome-Wide association between EYA1 and Aspirin-induced peptic ulcerationStephane Bourgeois, Daniel F Carr, Crispin O Musumba, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Software for Dosage Individualization of Voriconazole: a Prospective Clinical StudyWilliam Hope, Gary Johnstone, Silvia Cicconi, et al.
The Journal of Investigative Dermatology|July 22, 2018
A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for PsoriasisAmy C Foulkes, David S Watson, Daniel F Carr, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2016
Efavirenz and Metabolites in Cerebrospinal Fluid: Relationship with CYP2B6 c.516G→T Genotype and Perturbed Blood-Brain Barrier Due to Tuberculous MeningitisSam Nightingale, Tran Thi Hong Chau, Martin Fisher, et al.
The Journal of Antimicrobial Chemotherapy|August 23, 2014
CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populationsDaniel F Carr, Mas Chaponda, Elena M Cornejo Castro, et al.
The Journal of Investigative Dermatology|December 29, 2022
TNF-α‒Mediated Keratinocyte Expression and Release of Matrix Metalloproteinase 9: Putative Mechanism of Pathogenesis in Stevens‒Johnson Syndrome/Toxic Epidermal NecrolysisAnna Olsson-Brown, Vincent Yip, Emeka D Ogiji, et al.
Diabetologia|January 15, 2026
Identification of a genetic risk factor for metformin-induced vitamin B<sub>12</sub> deficiencyFaye D Baldwin, Khaled F Bedair, Andrea L Jorgensen, et al.
Clinical Pharmacology and Therapeutics|June 21, 2019
Genomewide Association Study of Statin-Induced Myopathy in Patients Recruited Using the UK Clinical Practice Research DatalinkDaniel F Carr, Ben Francis, Andrea L Jorgensen, et al.
Blood|October 17, 2013
CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemiaGillian G Johnson, Ke Lin, Trevor F Cox, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2011
The IL1RN promoter rs4251961 correlates with IL-1 receptor antagonist concentrations in human infection and is differentially regulated by GATA-1Enitan D Carrol, Antony Payton, Deborah Payne, et al.
Pageof 5